Published in AIDS Weekly, September 29th, 2003
Researchers in England conducted a study "to assess the impact of HIV status on the outcome of patients with non-small-cell lung cancer (NSCLC) in the era of highly active antiretroviral therapy (HAART)."
"Patients diagnosed with HIV-related NSCLC in the HAART era (since January 1996) were identified from a prospective single-center lung cancer database," explained T. Powles and coauthors at Chelsea and Westminster Hospital in London. "The clinicopathological characteristics and outcome of each HIV-positive patient were compared to three...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.